Archive for May, 2009

The Great Beyond: Extra excitement for exoplanet experiments

Extra excitement for exoplanet experiments - May 29, 2009. A-VB10b_art-640.jpg. Exoplaneteers have finally succeeded in using a technique called astrometry to spot a far off planet. Astrometry measures the change in the star’s position …

More: continued here

Sunday, May 31st, 2009

International Serious Adverse Events Consortium announces initial study resul…

The International Serious Adverse Events Consortium (SAEC) announced today initial results from its research designed to discover genetic markers that may predict individuals at risk for serious drug induced liver injury. The SAEC is a nonprofit research corporation, launched in the fall of 2007, comprised of and funded by 10 leading pharmaceutical companies and the Wellcome Trust.

More: continued here

Sunday, May 31st, 2009

Combined stem cell-gene therapy approach cures human genetic disease in vitro

A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem cell technology. The study, published in the May 31, 2009, early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.

More: continued here

Sunday, May 31st, 2009

To what extent can environmental pollutants and alcohol affect GI health?

New research quantifies the precise effects of environmental pollutants and alcohol intake on gastrointestinal (GI) health. Both studies being presented this week during Digestive Disease Week 2009 offer concrete evidence that the environment and alcohol intake can affect GI health and share important insights into new directions for future research.

More: continued here

Sunday, May 31st, 2009

2-drug combination appears safe and active in metastatic kidney cancer

Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial. Early data suggests that a combination of temsirolimus and bryostatin may be active in patients with rare forms of renal cell cancer, which are less likely to respond to other targeted therapies.

More: continued here

Sunday, May 31st, 2009

Penn researchers discover genetic risk factor for testicular cancer

Researchers at the University of Pennsylvania School of Medicine have uncovered variation around two genes that are associated with an increased risk of testicular cancer, which is the most common cancer among young men — it now affects seven out of 100,000 white men in the United States each year. The discovery, published in the May 31, 2009, online issue of Nature Genetics, is the first step toward understanding which men are at high risk of disease.

More: continued here

Sunday, May 31st, 2009

International Serious Adverse Events Consortium announces initial

International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury. Printer-friendly version. Chicago (June 1, 2009) ? …

More: continued here

Sunday, May 31st, 2009

2-drug combination appears safe and active in metastatic kidney

2-drug combination appears safe and active in metastatic kidney cancer. Printer-friendly version. ORLANDO (May 31, 2009)?Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic …

More: continued here

Sunday, May 31st, 2009

Penn researchers discover genetic risk factor for testicular

Penn researchers discover genetic risk factor for testicular cancer. Printer-friendly version. (PHILADELPHIA) ? Researchers at the University of Pennsylvania School of Medicine have uncovered variation around two genes that are …

More: continued here

Sunday, May 31st, 2009

how to save the US economy : Dynamics of Cats

Speculations on astronomy, astrophysics, news I find interesting, theoretical issues, science and science policy. I will digress into computational physics, science fiction and general issues and basically whatever I feel like whenever. …

More: continued here

Sunday, May 31st, 2009